Copyright
©The Author(s) 2022.
World J Clin Cases. Nov 6, 2022; 10(31): 11240-11251
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11240
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11240
Table 1 Mean abundance of gut microbiome taxa in patients with or without metabolically associated steatohepatitis
| Bacteria | No MASH (n = 22) | MASH (n = 35) |
| Bifidobacterium | 0.9 | 1.6 |
| Bacteroides | 38.3 | 56.9 |
| Parabacteroides | 2.0 | 1.2 |
| Prevotella | 21.7 | 5.5 |
| Blautia | 1.6 | 1.9 |
| Ruminococcus | 0.8 | 1.4 |
| Megasphaera | 1.5 | 1.5 |
| Sutterella | 1.3 | 0.9 |
- Citation: Wang JS, Liu JC. Intestinal microbiota in the treatment of metabolically associated fatty liver disease. World J Clin Cases 2022; 10(31): 11240-11251
- URL: https://www.wjgnet.com/2307-8960/full/v10/i31/11240.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i31.11240